Abstract
S138 Infliximab and Adalimumab Therapeutic Drug Monitoring (TDM): Analysis of >125,000 Patient Samples for Drug Levels and Designation of Anti-Drug Antibodies into Low, Intermediate and High Titers
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
